Liberman; Anita

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liberman; Anita.The latest application filed is for "methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone".

Company Profile

0.18.39

Liberman; Anita - Tel-Aviv IL
Liberman, Anita - Ramat Aviv IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
DNT-maleate and methods of preparation thereof Grant 7,842,717 - Ini , et al. November 30, 2	2010-11-30
2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride Grant 7,759,500 - Ini , et al. July 20, 2	2010-07-20
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole Grant 7,683,177 - Braude , et al. March 23, 2	2010-03-23
Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol Grant 7,683,080 - Liberman , et al. March 23, 2	2010-03-23
Method of stabilizing lansoprazole Grant 7,678,816 - Singer , et al. March 16, 2	2010-03-16
Methods For Preparing Eszopiclone Crystalline Form A, Substantially Pure Eszopiclone And Optically Enriched Eszopiclone App 20100029943 - MENDELOVICI; Marioara ; et al.	2010-02-04
Method for the purification of lansoprazole Grant 7,622,588 - Singer , et al. November 24, 2	2009-11-24
Process for the purification of duloxetine hydrochloride Grant 7,534,900 - Ini , et al. May 19, 2	2009-05-19
Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-Napathalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof App 20090012316 - Ini; Santiago ; et al.	2009-01-08
Sertraline hydrochloride form II and methods for the preparation thereof App 20080287550 - Schwartz; Eduard ; et al.	2008-11-20
Sertraline hydrochloride polymorphs App 20080176949 - Schwartz; Eduard ; et al.	2008-07-24
Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof Grant 7,399,871 - Ini , et al. July 15, 2	2008-07-15
Polymorphs Of Eszopiclone Malate App 20080027223 - Mainfeld; Alex ; et al.	2008-01-31
Sertraline hydrochloride form II and methods for the preparation thereof Grant 7,319,171 - Schwartz , et al. January 15, 2	2008-01-15
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole App 20080004319 - Braude; Viviana ; et al.	2008-01-03
Methods For Preparing Eszopiclone Crystalline Form A, Substantially Pure Eszopiclone And Optically Enriched Eszopiclone App 20070270590 - MENDELOVICI; Marioara ; et al.	2007-11-22
2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride App 20070191472 - Ini; Santiago ; et al.	2007-08-16
DNT-fumarate and methods of preparation thereof App 20070191471 - Ini; Santiago ; et al.	2007-08-16
DNT-maleate and methods of preparation thereof App 20070185192 - Ini; Santiago ; et al.	2007-08-09
Sertraline hydrochloride form II and methods for the preparation thereof App 20070093557 - Schwartz; Eduard ; et al.	2007-04-26
Sertraline hydrochloride form II and methods for the preparation thereof Grant 7,196,222 - Schwartz , et al. March 27, 2	2007-03-27
Sertraline hydrochloride form II and methods for the preparation thereof App 20070038005 - Schwartz; Eduard ; et al.	2007-02-15
Process for the purification of duloxetine hydrochloride App 20060276660 - Ini; Santiago ; et al.	2006-12-07
Crystal forms of (S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof App 20060270860 - Ini; Santiago ; et al.	2006-11-30
Pure duloxetine hydrochloride App 20060270731 - Ini; Santiago ; et al.	2006-11-30
Process for the preparation of optically active (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine App 20060270861 - Ini; Santiago ; et al.	2006-11-30
Sertraline hydrochloride polymorphs App 20060241189 - Schwartz; Eduard ; et al.	2006-10-26
Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof App 20060194869 - Ini; Santiago ; et al.	2006-08-31
Purification of tegaserod maleate App 20060128788 - Ini; Santiago ; et al.	2006-06-15
Method for the purification of lansoprazole Grant 7,060,837 - Singer , et al. June 13, 2	2006-06-13
Preparation of tegaserod and tegaserod maleate App 20060106086 - Ini; Santiago ; et al.	2006-05-18
Sertraline hydrochloride polymorphs Grant 7,022,881 - Schwartz , et al. April 4, 2	2006-04-04
Method for the purification of lansoprazole Grant 7,022,859 - Singer , et al. April 4, 2	2006-04-04
Method for the purification of lansoprazole App 20050165061 - Singer, Claude ; et al.	2005-07-28
Method for the purification of lansoprazole App 20050165059 - Singer, Claude ; et al.	2005-07-28
Method for the purification of lansoprazole App 20050165060 - Singer, Claude ; et al.	2005-07-28
Method for the purification of lansoprazole Grant 6,909,004 - Singer , et al. June 21, 2	2005-06-21
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole App 20050075370 - Braude, Viviana ; et al.	2005-04-07
Method of stabilizing lansoprazole App 20050020638 - Singer, Claude ; et al.	2005-01-27
Sertraline hydrochloride form II and methods for the preparation thereof App 20040220279 - Schwartz, Eduard ; et al.	2004-11-04
Sertraline hydrochloride polymorphs App 20040220280 - Schwartz, Eduard ; et al.	2004-11-04
Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol App 20040215021 - Liberman, Anita ; et al.	2004-10-28
Method for the purification of lansoprazole App 20040192923 - Singer, Claude ; et al.	2004-09-30
Novel synthesis and crystallization of peperazine ring-containing compounds App 20040176591 - Singer, Claude ; et al.	2004-09-09
Method for synthesizing leflunomide App 20040127532 - Avrutov, Ilya ; et al.	2004-07-01
Method for synthesizing leflunomide Grant 6,723,855 - Avrutov , et al. April 20, 2	2004-04-20
Methods for preparation of sertraline hydrochloride polymorphs Grant 6,600,073 - Schwartz , et al. July 29, 2	2003-07-29
Novel synthesis and crystallization of piperazine ring-containing compounds App 20030135043 - Singer, Claude ; et al.	2003-07-17
Novel synthesis and crystallization of piperazine ring-containing compounds App 20030120068 - Singer, Claude ; et al.	2003-06-26
Novel synthesis and crystallization of piperazine ring-containing compounds App 20030088094 - Singer, Claude ; et al.	2003-05-08
Novel synthesis and crystallization of piperazine ring-containing compounds App 20030069417 - Singer, Claude ; et al.	2003-04-10
Sertraline hydrochloride polymorphs App 20030055112 - Schwartz, Eduard ; et al.	2003-03-20
Sertraline hydrochloride polymorphs Grant 6,500,987 - Schwartz , et al. December 31, 2	2002-12-31
Sertraline hydrochloride Form II and methods for the preparation thereof Grant 6,495,721 - Schwartz , et al. December 17, 2	2002-12-17
Sertraline hydrochloride form II and methods for the preparation thereof App 20020183555 - Schwartz, Eduard ; et al.	2002-12-05
Method for systhesizing leflunomide App 20020022646 - Avrutov, Ilya ; et al.	2002-02-21
Novel synthesis and crystallization of piperazine ring-containing compounds App 20010051718 - Singer, Claude ; et al.	2001-12-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.